How cannabis affects the aging brain
Treatments studied
Part of Brain & nervous system clinical trials.
This study uses brain scans (fMRI) to see how THC (the active ingredient in cannabis) affects the brain as people age. If you are a cannabis user without current dependence or health issues, you may help researchers understand these effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used cannabis (marijuana) in the past 2 years and felt 'high' at least once.
- You are comfortable reading and speaking English.
- You do not currently have problems with cannabis use, like strong cravings or trying to quit.
- You have never had a bad reaction to cannabis.
- You are in generally good health with no serious medical conditions (like cancer, seizures, or a brain disorder).
- You can safely have an MRI scan (no metal implants, pacemaker, or severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how THC (from cannabis) changes brain signals during working memory tasks. It uses EEG and MEG (noninvasive brain recording) to understand changes in “neural noise” and how well information moves through memory networks.
This study tests different ratios of CBD to THC to see how CBD can change the effects of THC. It may help people who use cannabis occasionally understand how CBD can reduce unwanted side effects.
This trial studies how a single dose of THC (the active ingredient in cannabis) affects older adults. It aims to understand the effects in this age group, which may help guide safe use.
This early study measures how a THC dose (by mouth or vaporized form) moves through the body and how it affects the body’s responses. It mainly looks at safety and how THC behaves in older adults, including people who have used cannabis before.
This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.
This Phase 1 study tests how delta-9 THC (the main active ingredient in cannabis) affects healthy adults, and whether the effects differ by gender. It may help researchers understand risks and responses to THC, which could guide safer use and future treatments.
Hear when a new THC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.